Breast Cancer
67 Articles & Excerpts
Tamoxifen
by National Cancer Institute
Tamoxifen (Nolvadex®) is a medication in pill form that interferes with the activity of estrogen (a hormone). Tamoxifen has been used for more than 20 years to treat patients with advanced breast cancer.
Breast Cancer : Mammography Saves Lives
by Food and Drug Administration (FDA)
Widespread screening programs for women 50 and over can reduce breast cancer death rates by 30 percent. A new analysis of a study by the Health Insurance Plan of Greater New York published by the National Cancer Institute (NCI) in 1988 showed
Breast Cancer Treatments, Drug Options Expand
by Food and Drug Administration (FDA)
Every three minutes in the United States, a woman learns she has breast cancer. But new treatments and better diagnostics have improved the outlook for many. Breast cancer can be treated with surgery, radiation and drugs.
Breast Cancer Treatment
by National Cancer Institute
The most common type of breast cancer is ductal carcinoma, which begins in the cells of the ducts. Cancer that begins in the lobes or lobules is called lobular carcinoma and is more often found in both breasts than are other types of breast cancer.
Breast Cancer Treatment Options
by National Cancer Institute
Once you receive your doctor's opinion about what treatments you need, you have the right to get more advice before you make up your mind. Other doctors' opinions can help you make one of the most important decisions of your life.
Male Breast Cancer Treatment
by National Cancer Institute
Different types of treatment are available for men with breast cancer. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials.
Breast Cancer Risk
by National Cancer Institute
This fact sheet provides information on the Breast Cancer Risk Assessment Tool and about breast cancer risk and the drug tamoxifen. Study results from the Breast Cancer Prevention Trial show that tamoxifen can reduce the likelihood of developing breast
Breast Cancer : Determining Therapy, Reconstruction Options
by Food and Drug Administration (FDA)
Treatment is based on the extent of the disease and the biology of the specific tumor. Evaluation of these factors guides the approach to surgery and, if needed, adjuvant therapy. In addition, a woman's age and menopausal status are significant.
Breast Cancer : The Estrogen Connection, Anatomy of a Disease
by Food and Drug Administration (FDA)
Of increasing interest is the possible relation of a high-fat diet to breast cancer. The death rate from breast cancer is highest in countries, including the United States, in which the intake of fat and animal protein is high.
Breast Cancer Prevention
by National Cancer Institute
Doctors cannot always explain why one person gets cancer and another does not. However, scientists have studied general patterns of cancer in the population to learn what things around us and what things we do in our lives may increase our chance
Understanding Breast Cancer Treatment
by National Cancer Institute
What Causes Breast Cancer? Each year in the United States, almost 180,000 women are told they have breast cancer. Upon hearing this unexpected and overwhelming news, a woman is faced with having to make treatment choices within a short period of time.
Treatment Improves Outlook for Breast Cancer
by National Cancer Institute
Study researchers found that letrozole, when taken after five years of tamoxifen therapy, substantially increased the chance of remaining cancer free. In total, 132 women taking the placebo had their disease recur compared to 75 on letrozole.
Male Breast Cancer
by National Cancer Institute
Breast cancer may occur in men. Men at any age may develop breast cancer, but it is usually detected (found) in men between 60 and 70 years of age. Male breast cancer makes up less than 1% of all cases of breast cancer.
Probability of Breast Cancer in American Women
by National Cancer Institute
An estimated risk represents the average risk for all women in the United States as a group. This estimate does not indicate the risk for an individual woman because of individual differences in age, family history, reproductive history, race / ethnicity
Exemestane Boosts Survival in Breast Cancer
by National Cancer Institute
Following surgery for breast cancer, women whose tumors grow in response to the hormone estrogen usually take the anti-estrogen drug tamoxifen for five years to reduce their risk that the disease will recur.
Mammography, Stages of Breast Cancer
by Food and Drug Administration (FDA)
The American Cancer Society says that the best strategy for successfully beating breast cancer is to follow guidelines for early detection. Currently, the most effective technique for early detection is screening mammography, an x-ray procedure that can
Cancer Risk in Ashkenazi Jews
by National Cancer Institute
In 1995, scientists from the National Institutes of Health (NIH) discovered that a particular alteration in the breast cancer gene called BRCA1 was present in 1 percent of the general Jewish population.
Breast Cancer Adjuvant Therapy
by National Cancer Institute
Researchers have been studying breast cancer for many years to learn how best to treat this disease. They have given special attention to ways to prevent breast cancer from recurring (returning) after primary treatment.
Breast Cancer: Woman Is Partner in Choosing Treatment
by Food and Drug Administration (FDA)
This conclusion to a two-part series discusses new approaches to diagnosting and treating breast cancer that are giving women an unprecedented opportunity to share with their physicians decisions about surgery, radiation and chemotherapy.
Breast Cancer Detection and Diagnosis
by National Cancer Institute
The National Cancer Institute (NCI) is funding numerous research projects to improve conventional mammography (an x-ray technique to visualize the internal structure of the breast) and develop other imaging technologies to detect, diagnose
| 